Clinical trial

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

NCT03275311

Study summary

ClinicalTrials.gov

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record above.

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2014-07-01

PhaseN/A

Conditions

Metastatic Breast Cancerunresolved

Interventions

Sponsors & collaborators

UNICANCERlead sponsor

Roche Pharma AGcollaborator

Pierre Fabre Laboratoriescollaborator

Pfizercollaborator

AstraZenecacollaborator

Merck Sharp & Dohme LLCcollaborator

Eisai Inc.collaborator

Daiichi Sankyocollaborator

Eli Lilly and Companycollaborator

Gilead Sciencescollaborator

Seagen Inc.collaborator

Mapped research locations

ParisFrance1 ToulouseFrance1 MarseilleFrance1 MontpellierFrance1 LyonFrance1 StrasbourgFrance1 LilleFrance1 BordeauxFrance1 NantesFrance1 RennesFrance1 NiceFrance1 DijonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03275311 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.